Literature DB >> 11315768

Nephron distribution of total low Km cyclic AMP phosphodiesterase in mouse, rat and rabbit kidney.

E Kusano1, I Yoshida, S Takeda, S Homma, A N Yusufi, T P Dousa, Y Asano.   

Abstract

The activity of cAMP degradation enzyme, cAMP phosphodiesterase (cAMP PDE), in renal tubules is a critically important factor in determining cellular cAMP levels, particularly in response to hormones. In this study we examine the nephron distribution of cAMP PDE activity in the mouse, rat and rabbit kidney and important cellular regulators of cAMP PDE, namely calmodulin and adenosine triphosphate (ATP). We assayed total low Km cAMP PDE in microdissected tubule segments, using 10(-6) M (3H) cAMP as a substrate. Activities were expressed in fentomol cAMP hydrolyzed per minute per mm tubular length or per one glomerulus. The content of ATP was measured in outer medullary collecting duct and medullary thick ascending limb of Henle's loop with microbioluminescence assay using firefly luciferase. In mouse kidney, cAMP PDE was significantly higher in all tubular segments compared to glomerulus. Proximal convoluted tubule, proximal straight tubule, medullary thick ascending limb of Henle's loop (mTAL), and outer medullary collecting duct (OMCD) had intermediated activity. Greater cAMP PDE activity was detected in cortical ascending limb of Henle's loop (cTAL), cortical collecting duct and in distal convoluted tubule (DCT). The highest activity was found in connecting tubules. In rat, nephron distribution of cAMP PDE activities was similar to mouse, except that activity in glomeruli was higher than in mouse glomeruli. In rabbit, nephron distribution of cAMP PDE activities was different from those of mouse and rat. There was no single prominent segment with high cAMP PDE activity. DCT and cTAL showed low enzyme activity. Overall, the highest cAMP PDE activities were measured in the mouse and the lowest were measured in the rabbit nephrons, with those of rat nephron showing an intermediate activity. The maximum effective dose of the calmodulin antagonist, trifluoperazine (200 microM), inhibited cAMP PDE in all nephron segments from the rat kidney. However, there is no statistical significance of its inhibition among nephron segments. In OMCD and mTAL of the rat kidney, cAMP PDE activity was inhibited by ATP (5 mM to approximately 10 mM) which is far beyond the physiological concentartion of ATP in normal epithelial cell. Actual determinations of ATP in mTAL and OMCD were 0.1 mM and 0.17 mM, respectively. These observations show that distal segments of tubules have more active catabolism of cAMP than proximal segments. cAMP PDE in each nephron segment appear to be almost equally dependent on trifluoperazine-sensitive pathway that may reflect the Ca2+-calmodulin system. Cellular concentration of ATP might not be involved in the regulation of the total low Km cAMP PDE activity in rat mTAL and OMCD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11315768     DOI: 10.1620/tjem.193.207

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  10 in total

1.  Calmodulin is required for vasopressin-stimulated increase in cyclic AMP production in inner medullary collecting duct.

Authors:  Jason D Hoffert; Chung-Lin Chou; Robert A Fenton; Mark A Knepper
Journal:  J Biol Chem       Date:  2005-02-14       Impact factor: 5.157

2.  Pendrin protein abundance in the kidney is regulated by nitric oxide and cAMP.

Authors:  Monika Thumova; Vladimir Pech; Otto Froehlich; Diana Agazatian; Xiaonan Wang; Jill W Verlander; Young Hee Kim; Susan M Wall
Journal:  Am J Physiol Renal Physiol       Date:  2012-07-18

Review 3.  Drug discovery for polycystic kidney disease.

Authors:  Ying Sun; Hong Zhou; Bao-xue Yang
Journal:  Acta Pharmacol Sin       Date:  2011-06       Impact factor: 6.150

4.  Modulation of Polycystic Kidney Disease Severity by Phosphodiesterase 1 and 3 Subfamilies.

Authors:  Hong Ye; Xiaofang Wang; Caroline R Sussman; Katharina Hopp; Maria V Irazabal; Jason L Bakeberg; Wells B LaRiviere; Vincent C Manganiello; Charles V Vorhees; Haiqing Zhao; Peter C Harris; Jan van Deursen; Christopher J Ward; Vicente E Torres
Journal:  J Am Soc Nephrol       Date:  2015-09-15       Impact factor: 10.121

5.  Effects of hydration in rats and mice with polycystic kidney disease.

Authors:  Katharina Hopp; Xiaofang Wang; Hong Ye; María V Irazabal; Peter C Harris; Vicente E Torres
Journal:  Am J Physiol Renal Physiol       Date:  2014-12-10

6.  Tolvaptan plus pasireotide shows enhanced efficacy in a PKD1 model.

Authors:  Katharina Hopp; Cynthia J Hommerding; Xiaofang Wang; Hong Ye; Peter C Harris; Vicente E Torres
Journal:  J Am Soc Nephrol       Date:  2014-07-03       Impact factor: 10.121

7.  Cyclic nucleotide signaling in polycystic kidney disease.

Authors:  Xiaofang Wang; Christopher J Ward; Peter C Harris; Vicente E Torres
Journal:  Kidney Int       Date:  2009-11-18       Impact factor: 10.612

Review 8.  Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling.

Authors:  Caroline R Sussman; Xiaofang Wang; Fouad T Chebib; Vicente E Torres
Journal:  Cell Signal       Date:  2020-04-23       Impact factor: 4.315

9.  Generation and phenotypic characterization of Pde1a mutant mice.

Authors:  Xiaofang Wang; Satsuki Yamada; Wells B LaRiviere; Hong Ye; Jason L Bakeberg; María V Irazabal; Fouad T Chebib; Jan van Deursen; Peter C Harris; Caroline R Sussman; Atta Behfar; Christopher J Ward; Vicente E Torres
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

Review 10.  Physiology and pathophysiology of the vasopressin-regulated renal water reabsorption.

Authors:  Michelle Boone; Peter M T Deen
Journal:  Pflugers Arch       Date:  2008-04-23       Impact factor: 3.657

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.